Detalles de la búsqueda
1.
Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis.
Am J Nephrol
; 55(2): 127-135, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38091973
2.
Global real-world data on hemodiafiltration: An opportunity to complement clinical trial evidence.
Semin Dial
; 35(5): 440-445, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35439847
3.
Switching from high-flux dialysis to hemodiafiltration: Cost-consequences for patients, providers, and payers.
Semin Dial
; 35(5): 405-412, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35301753
4.
Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study.
BMC Nephrol
; 20(1): 396, 2019 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31664928
5.
One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis.
J Ren Nutr
; 29(5): 428-437, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30679076
6.
Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.
Am J Nephrol
; 47(3): 153-161, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29514139
7.
Effects of dialysate to serum sodium (Na+) alignment in chronic hemodialysis (HD) patients: retrospective cohort study from a quality improvement project.
BMC Nephrol
; 19(1): 75, 2018 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29609536
8.
Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy dataâ©.
Clin Nephrol
; 88(8): 59-67, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28587714
9.
Effects of Crit-Line® monitor use on patient outcomes and epoetin alfa dosing following onset of hemodialysis: a propensity score-matched study.
Blood Purif
; 37(3): 249-57, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24970017
10.
Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes.
Kidney Int
; 83(6): 1177-84, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23466993
11.
Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.
J Am Soc Nephrol
; 23(3): 516-24, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22266664
12.
A real-world analysis of the influence of age on maintenance hemodialysis patients: managing serum phosphorus with sucroferric oxyhydroxide as part of routine clinical care.
Int Urol Nephrol
; 55(2): 377-387, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953565
13.
An Innovative Approach to Minimizing Downtime in Continuous Kidney Replacement Therapy.
ASAIO J
; 69(6): e250-e255, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36976305
14.
Real-World Performance of High-Flux Dialyzers in Patients With Hypoalbuminemia.
ASAIO J
; 68(1): 96-102, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34172639
15.
Serum Phosphorus and Pill Burden Among Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide: One-Year Follow-Up on a Contemporary Cohort.
Int J Nephrol Renovasc Dis
; 15: 139-149, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35431567
16.
Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-ß-D-glucosaminidase.
Kidney Int
; 79(4): 464-70, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20980978
17.
A test for the relationship between a time-varying marker and both recovery and progression with missing data.
Stat Med
; 30(7): 718-24, 2011 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21394748
18.
Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis.
Int J Nephrol Renovasc Dis
; 14: 11-21, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33505168
19.
Effect of Citrate-Acidified Dialysate on Intact Parathyroid Hormone in Prevalent Hemodialysis Patients: A Matched Retrospective Cohort Study.
Int J Nephrol Renovasc Dis
; 14: 475-486, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34992426
20.
Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study.
Clin Kidney J
; 14(7): 1770-1779, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34221384